Literature DB >> 9199308

Insulin-like growth factor I receptor signaling in transformation by src oncogenes.

B Valentinis1, A Morrione, S J Taylor, R Baserga.   

Abstract

R- cells, a line of mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I (IGF-I) receptor genes, are refractory to transformation by several viral and cellular oncogenes. Using colony formation in soft agar as a measure of full transformation, we report here that R- cells can be transformed by v-src, although they still cannot be transformed by the activated c-src527 (mutation at tyrosine 527 to phenylalanine), which readily transforms mouse embryo cells with a wild-type number of IGF-I receptors (W cells). Although v-src is a more potent inducer of tyrosine phosphorylation than c-src527, the extent of phosphorylation of either insulin receptor substrate 1 or Shc, two of the major substrates of the IGF-I receptor, does not seem sufficiently different to explain the qualitative difference in soft agar growth. v-src, however, is considerably more efficient than c-src527 in its ability to tyrosyl phosphorylate, in R- cells, the focal adhesion kinase, Stat1, and p130cas. These results indicate that v-src, but not c-src527, can bypass the requirement for a functional IGF-I receptor in the full transformation of mouse embryo fibroblasts and suggest that qualitative and quantitative differences between the two oncogenes can be used to identify some of the signals relevant to the mechanism(s) of transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199308      PMCID: PMC232226          DOI: 10.1128/MCB.17.7.3744

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  81 in total

Review 1.  Oncogenes and the strategy of growth factors.

Authors:  R Baserga
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

2.  Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.

Authors:  H I Pass; D J Mew; M Carbone; W A Matthews; J S Donington; R Baserga; C L Walker; M Resnicoff; S M Steinberg
Journal:  Cancer Res       Date:  1996-09-01       Impact factor: 12.701

3.  Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor.

Authors:  A Craparo; T J O'Neill; T A Gustafson
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

4.  Association of insulin receptor substrate 1 with simian virus 40 large T antigen.

Authors:  Z L Fei; C D'Ambrosio; S Li; E Surmacz; R Baserga
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

5.  The insulin-like growth factor I receptor: a key to tumor growth?

Authors:  R Baserga
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

6.  Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction.

Authors:  D Altschuler; K Yamamoto; E G Lapetina
Journal:  Mol Endocrinol       Date:  1994-09

7.  The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1.

Authors:  L Yenush; K J Makati; J Smith-Hall; O Ishibashi; M G Myers; M F White
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

8.  Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.

Authors:  H Werner; Z Shen-Orr; F J Rauscher; J F Morris; C T Roberts; D LeRoith
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

9.  Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain.

Authors:  S Li; A Ferber; M Miura; R Baserga
Journal:  J Biol Chem       Date:  1994-12-23       Impact factor: 5.157

10.  c phosphorylation and activation of the IGF-I receptor in src-transformed cells.

Authors:  J E Peterson; T Jelinek; M Kaleko; K Siddle; M J Weber
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

View more
  13 in total

1.  Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.

Authors:  Deirdre A Buckley; Alan Cheng; Patrick A Kiely; Michel L Tremblay; Rosemary O'Connor
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 2.  IGF-I receptor signalling in transformation and differentiation.

Authors:  B Valentinis; R Baserga
Journal:  Mol Pathol       Date:  2001-06

Review 3.  Function of the IGF-I receptor in breast cancer.

Authors:  E Surmacz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-01       Impact factor: 2.673

4.  A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.

Authors:  Yixing Jiang; Liwei Wang; Weida Gong; Daoyan Wei; Xiangdong Le; James Yao; Jaffer Ajani; James L Abbruzzese; Suyun Huang; Keping Xie
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

5.  Growth of v-src-transformed cells in serum-free medium through the induction of growth factors.

Authors:  Tiziana Deangelis; Andrew Quong; Andrea Morrione; Renato Baserga
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

6.  Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Authors:  Ming Yin; Xiaoxiang Guan; Zhongxin Liao; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-30       Impact factor: 4.060

7.  Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma.

Authors:  Ardeshir Hakam; Quan Fang; Richard Karl; Domenico Coppola
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

Review 8.  Targeting insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Jennifer Wu; Andrew X Zhu
Journal:  J Hematol Oncol       Date:  2011-07-05       Impact factor: 17.388

9.  The insulin receptor: a new target for cancer therapy.

Authors:  Roberta Malaguarnera; Antonino Belfiore
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-06       Impact factor: 5.555

10.  IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.

Authors:  Michal Rajski; Rosanna Zanetti-Dällenbach; Brigitte Vogel; Richard Herrmann; Christoph Rochlitz; Martin Buess
Journal:  BMC Med       Date:  2010-01-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.